The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

New Cancer Drug Gets Dramatic Results

August 25, 2010 1:39 pm | by Massachusetts Institute of Technology | News | Comments

Researchers call the experimental drug a major success for targeted cancer therapies.

Pancreatic cancer research moving forward

August 25, 2010 1:37 pm | by Baylor College of Medicine | News | Comments

The Elkins Pancreas Center at Baylor College of Medicine , in partnership with the NCI-designated Dan L. Duncan Cancer Center at BCM, works to find new, more effective therapies for pancreatic cancer through clinical and basic science research. "When people talk about pancreatic cancer it...


ViewRay Secures Series C Financing

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

CLEVELAND, Aug. 25 /- ViewRay™, Inc., a privately held medical device company, has secured $20 million in Series C financing led by new investor Siemens Venture Capital (SVC) GmbH and joined by existing investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and...


Ambry Genetics Announces the Addition of Illumina HiSeq 2000 and First 510(K) Approved BeadXpress® to Its Sequencing and Genotyping Capabilities

August 25, 2010 1:37 pm | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Aug. 25 /- Ambry Genetics, a global leader in genomic services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System. Ambry Genetics has been...


GE Animals to Exhibit at Livestock Biotech Summit

August 25, 2010 1:37 pm | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Wednesday, August 25, 2010) - The Biotechnology Industry Organization (BIO) will present an exciting exhibit of genetically engineered (GE) animal technologies at its Livestock Biotech Summit. The first national industry conference on GE animal technologies will take...


Ironman Competitor with Diabetes Encourages Others to Live Without Limits; Inspiring Triathlete Participates in Health Fair at The Medicine Stop 5525 South Pulaski Road, Chica...

August 25, 2010 1:35 pm | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 25 /- WHO/ WHAT:   As part of an inspirational nationwide tour, "Iron Andy" Holder, a triathlete who was diagnosed with type 1 diabetes at age 36, will be at The Medicine Stop in Chicago on Thursday, August 26 from 1:00 pm – 4:00 pm. He will speak to patients at...


Sysmex America Awarded National Novation GPO Contract for Automated Urinalysis

August 25, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

MUNDELEIN, Ill., Aug. 25 /- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation.  Novation is the leading...


U.S. Navy Reaches Agreement to Purchase QBC STAR Hematology Analyzers for Use on its Surface Fleet

August 25, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

PORT MATILDA, Pa., Aug. 25 /- QBC Diagnostics was awarded one of the largest contracts in company history, as the United States Navy has agreed to install QBC STAR hematology analyzers on surface ships throughout the world. The QBC STAR provides users a 9-parameter complete blood count...


TimeOut Capsules: Undeclared Drug Ingredient

August 25, 2010 1:30 pm | by U.S. Food & Drug Administration | News | Comments

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.


Stryker buys Gaymar Industries for $150 million

August 25, 2010 9:45 am | by The Associated Press | News | Comments

Medical device maker Stryker Corp. said Wednesday it agreed to buy privately held Gaymar Industries for $150 million in cash.The boards of both companies have approved the sale, which is expected to close by Oct. 1.Stryker, which makes hip and knee implants and other orthopedic devices and...

Career Direction for Children – Preparing for Sustainable Careers in Growth Industries

August 25, 2010 9:38 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., August 24, 2010 - Children are fascinated by things their parents no longer see, solve problems with simple solutions, and if left to explore, are naturally exhilarated by learning. The first step in providing career direction for children is making sure they have simple...

Brain imaging gives new insight into mental disorders

August 25, 2010 9:36 am | by Baylor College of Medicine | News | Comments

A new kind of psychiatry built on objective measures derived from functional magnetic resonance imaging (or fMRI) of the brain performed while patients play economic games could provide new insight into the diagnosis and, eventually, treatment of mental disorders, said researchers from...


AACR Supports NIH Stem Cell Research

August 25, 2010 9:34 am | by AACR | News | Comments

PHILADELPHIA - The American Association for Cancer Research (AACR), the world's oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, was funded by the National Institutes of...


MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient

August 25, 2010 9:30 am | by U.S. Food & Drug Administration | News | Comments

UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.


Advanced CNC Machining Allows for Dramatic Improvements in R & D and Production Output for Surgical Toolmaker

August 25, 2010 8:58 am | by Stryker | Articles | Comments

The Stryker Corporation’s highly specialized System 6 power tools, which include high-precision handheld devices such as oscillating bone saws, demand frequent manufacturing requirements for low quantities of these devices. This presents an ongoing challenge for the Production Group’s management team at the company’s main manufacturing location in Kalamazoo. The location is also home to the company’s Experimental Group, which investigates new technologies, advanced materials, and various manufacturing protocols in an effort to maintain optimal productivity for the company. Production Part Approval Process (PPAP) protocols are strategized here as well.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.